Table 3.
Control disease highlights.
| Reference | Highlights |
|---|---|
| Ghosh, Gupta and Misra, 2020 [9] | Discussing the feasibility of telehealth in providing patients with diabetes the best care |
| Peters and Garg, 2020 [10] | Discussing the provision of diabetes care remotely through telehealth during the COVID-19 pandemic |
| Boscari, Ferretto, Uliana, Avogaro and Bruttomesso, 2021 [11] | Evaluating the effects of telemedicine visits on patients with type 1 diabetes. |
| Mgbako, Miller, Santoro, Remien, Shalev, Olender, Gordon and Sobieszczyk, 2020 [12] | Discussing the global disruption of HIV care delivery and the use of telehealth to maintain HIV treatment adherence in COVID-19 |
| Rogers, Coats, Adams, Murphy, Stewart, Arnold, Chan and Nunn, 2020 [13] | Reviewing clinic's transition to telehealth and implications for providing HIV prevention and care services via telehealth during the COVID-19 pandemic |
| Roncero, García-Ullán, Javier, Martín, Andrés, Ojeda, González-Parra, Pérez, Fombellida and Álvarez-Navares, 2020 [14] | Describing the implementation of telehealth programs to assist people with mental health problems in the COVID-19 context |
| Miu, Vo, Palka, Glowacki and Robinson, 2020 [15] | Discussing treatment engagement for people with serious mental illness Discussing populations that rapidly switched to telehealth. |
| Moring, Dondanville, Fina, Hassija, Chard, Monson, LoSavio, Wells, Morland and Kaysen, 2020 [16] | Discussing how to effectively deliver telehealth and in‐person mental health therapy during the pandemic |
| Kuroda, 2020 [17] | Discussing strengths and weaknesses of telehealth with respect to patients with epilepsy during the COVID-19 pandemic |
| Punia, Nasr, Zagorski, Lawrence, Fesler, Nair and Najm, 2020 [18] | Discussing the delivery of outpatient clinical care to patients with epilepsy amidst the COVID-19 pandemic |
| Lonergan, Washington III, Branagan, Gleason, Pruthi, Carroll and Odisho, 2020 [19] | Discussing challenges in providing care and continuous support to patients with cancer in the Comprehensive Cancer Centre and during the COVID-19 pandemic |
| Zaorsky, James, McBride, Dess, Jackson, Mahal, Chen, Choudhury, Henry and Syndikus, 2020 [20] | Discussing the framework for the evaluation of patients with prostate cancer to assess therapy management decisions through telehealth during the COVID-19 pandemic |
| Kang, Wong, Sherman, Rybkin, McBride, Riaz, Tsai, Yu, Chen and Zakeri, 2020 [21] | Implementing telehealth and multidisciplinary approach to the continued provision of standard‐of‐care treatments for patients with cancer during the COVID-19 pandemic |
| Lee, Cho, Lau, Cheng, Wong, Ku, Chan and Yeung, 2020 [22] | Managing the disruption of healthcare cancer services during the COVID-19 pandemic |
| Kotsen, Dilip, Carter-Harris, O'Brien, Whitlock, de Leon-Sanchez and Ostroff, 2020 [23] | Examining the evolution from in-person counselling services to virtual telehealth treatments for tobacco-dependent patients with cancer during the COVID-19 pandemic |
| Smrke, Younger, Wilson, Husson, Farag, Merry, Macklin-Doherty, Cojocaru, Arthur and Benson, 2020 [24] | Delivery of cancer care through telehealth to patients living far from the health centres during the COVID-19 pandemic. |
| Atreya, Kumar, Samal, Bhattacharya, Banerjee, Mallick, Chakraborty, Gupta and Sarkar, 2020 [25] | Exploratory survey to assess the changes in hospital-based practices to raise caregiver's/patient's awareness about the telehealth services provided for cancer care during the COVID-19 pandemic |
| Al‐Shamsi, Alhazzani, Alhuraiji, Coomes, Chemaly, Almuhanna, Wolff, Ibrahim, Chua and Hotte, 2020 [26] | Reviewing potential challenges associated with the management of patients with cancer while suggesting practical approaches during the COVID-19 pandemic |
| Prasad, Brewster, Newman and Rajasekaran, 2020 [27] | Discussing different guidelines for using telehealth to maintain a continuum of care for patients with cancer during the COVID-19 pandemic |
| Jonker, Lahr, Oonk, de Bock and van Leeuwen, 2021 [28] | Discussing the effects of telemonitoring on cancer patients by evaluating post-charge physical activity, vital signs and patient-reported symptoms of older patients post-discharge after oncological surgery |